Arthritis National Research Foundation
Arthritis National Research Foundation is a 501(c)(3) non-profit that provides grant funding to early-career scientists researching arthritis and autoimmune diseases, while operating Immune Boost Capital, an evergreen venture fund reinvesting all returns into immune-related research.
- Company typePrivate
- Founded1952
- HeadquartersIrvine, United States
- Headcount1–10
- GTM typeB2C
- OfferingServices
What Arthritis National Research Foundation does
Arthritis National Research Foundation (ANRF) is a 501(c)(3) non-profit research foundation founded in 1952 and headquartered in Irvine, California. Its core function is providing research grant funding to early-career scientists working on arthritis and related autoimmune diseases, addressing a documented funding gap for promising research and the career-establishment challenges faced by investigators entering the field. ANRF's stated impact metrics indicate that 98% of its grantees remain in science and over 87% of awardees secure follow-on funding for their ANRF-originated projects.
ANRF's product surface is organized around a small number of distinct offerings. The central product is the Research Grants Program, awarded through a website-based application process with review by a Scientific Advisory Board and approval by the Board of Directors. The foundation also operates Immune Boost Capital, a wholly-owned evergreen venture fund that provides proof-of-concept capital to early-stage therapies, diagnostics, and technologies for immune-mediated diseases, with 100% of returns reinvested into research. Supporting products include the "In the Rheum" podcast, a clinical trials information hub, the "60 Minutes to Save Millions" virtual fundraising event, and the annual Arthritis and Lupus Awareness Month campaign. ANRF's Scientific Advisory Board is composed of former ANRF grant recipients, creating a self-reinforcing review ecosystem.
The foundation operates on a donation-driven revenue model. Income is generated through individual donations, tribute gifts, matched giving campaigns (including a 1:1 match on its May 15, 2026 Day of Giving), and event ticket sales ($30 per ticket for the 2026 virtual fundraiser). ANRF markets through a multi-channel approach spanning social media (Facebook, X, Instagram, LinkedIn, Pinterest, YouTube), its curearthritis.org website, email, webinars, and celebrity/athlete partnerships. Geographic focus is the United States, and the foundation states that 2026 represents the largest investment and most grantees in its history, with record research funding applications received.
Arthritis National Research Foundation firmographics
Firmographics- Name
- Arthritis National Research Foundation
- Legal name
- Arthritis National Research Foundation
- Website
- https://curearthritis.org
- Company type
- Private
- Founded year
- 1952
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Arthritis National Research Foundation is a 501(c)(3) non-profit that provides grant funding to early-career scientists researching arthritis and autoimmune diseases, while operating Immune Boost Capital, an evergreen venture fund reinvesting all returns into immune-related research.
- Ownership category
- akta.pro rank
Arthritis National Research Foundation industry classification
Industry- Product category
- Nonprofit Medical Research Foundation
- NAICS
- Voluntary Health Organizations (813212), Grantmaking and Giving Services (81321)
- SIC
- Services-Social Services (8300)
- akta.pro primary industry
- Health & Medical Research Grantmaking Foundations (BPAGAKAL)
- akta.pro secondary industries
- Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA), Research & Science Grantmaking Foundations (BPAGAKAI)
Keywords
Where Arthritis National Research Foundation is headquartered
LocationHeadquarters
- HQ city
- Irvine
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Arthritis National Research Foundation business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Others, Operations, Marketing or Sales, Personnel
Revenue model
- Donations and Charitable Contributions: ANRF raises funds through individual donations, tribute gifts in honor of others, and special giving campaigns such as matched giving days. The foundation operates with 100% of returns from its Immune Boost Capital venture fund reinvested into arthritis and autoimmune disease research.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | One time | Virtual fundraiser tickets for '60 Minutes to Save Millions' event |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels7 records
Arthritis National Research Foundation product offering
Product offeringCore offering
ANRF provides research grant funding to early-career scientists conducting research on arthritis and autoimmune diseases, with the goal of advancing treatments and finding cures. The foundation also operates Immune Boost Capital, an evergreen venture fund that invests in early-stage autoimmune disease therapeutics and diagnostics, reinvesting 100% of returns to sustain ongoing research funding.
Product overview
The Arthritis National Research Foundation (ANRF) operates as a research funding organization rather than a traditional product company. ANRF's primary offerings include research grants for early-career scientists focused on arthritis and autoimmune diseases, an evergreen venture fund called Immune Boost Capital that supports early-stage therapeutics and diagnostics, virtual fundraising events like '60 Minutes to Save Millions', annual awareness campaigns including Arthritis and Lupus Awareness Month, and educational resources such as the 'In the Rheum' podcast and clinical trials information hub. The foundation's model reinvests all returns from its venture fund to sustain continuous innovation in immune-related disease research.
Differentiator
Problem solved
Functional benefit
Products and services
- Research Grants Program ANRF's core research grant program that funds early-career scientists conducting research to improve treatments and find a cure for arthritis and related autoimmune diseases, supporting researchers in establishing sustainable research careers. Applications are submitted through the website and reviewed by the Scientific Advisory Board.
- Immune Boost Capital ANRF's evergreen venture fund that supports early-stage autoimmune disease therapeutics and diagnostics by providing proof-of-concept capital and reinvesting 100% of returns to sustain innovation in immune-related disease research.
Quantifiable outcome
- 98% of ANRF grantees stay in science
- +3 more outcomes
Companies that use Arthritis National Research Foundation
Customer profileSegments3 records
Ideal customer profiles3 records
Arthritis National Research Foundation technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Arthritis National Research Foundation partnerships and signals
Strategic signalScale indicators5 records
Recent moves5 records
Expansion highlights5 records
Arthritis National Research Foundation competitors and assessment
Company assessmentDirect peers
- Arthritis Foundation: The largest U.S. nonprofit focused on arthritis, funding research, advocacy, and patient programs. Directly comparable to ANRF in mission area and donor base, but at substantially larger scale.
- National Psoriasis Foundation: Funds psoriatic disease and psoriatic arthritis research while running patient advocacy programs. Comparable nonprofit grantmaking model for a specific autoimmune condition overlapping ANRF's research scope.
- Lupus Research Alliance: Largest nonprofit funder of lupus research worldwide, with a similar grantmaking model focused on autoimmune disease. Comparable in disease-specific focus and early-career funding strategy.
- Sjögren's Foundation: Disease-specific nonprofit funding Sjögren's research, explicitly listed among ANRF's focus areas. Comparable mission, donor base, and grantmaking structure.
- Scleroderma Foundation: Nonprofit supporting scleroderma research and patients. Operates a similar grantmaking-plus-patient-services model to ANRF in an adjacent autoimmune disease area.
- Rheumatology Research Foundation: The research arm of the American College of Rheumatology, funding rheumatology research and training. Closely comparable to ANRF in funding early-career researchers studying rheumatic and autoimmune diseases.
Others
- Cystic Fibrosis Foundation: Disease-focused nonprofit famous for pioneering the venture philanthropy model that ANRF's Immune Boost Capital emulates. Strategically comparable as the archetype for nonprofit-led biotech investment.
- Cure SMA: Nonprofit funding spinal muscular atrophy research with a similar model combining research grants, patient education, and donor-driven fundraising. Comparable as a small, disease-specific research funding charity.
Broad incumbents
- American College of Rheumatology: Professional society for rheumatologists that runs research, training, and policy programs. Comparable as a rheumatology ecosystem incumbent, though more clinician-focused than ANRF's donor-driven model.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Arthritis National Research Foundation social profiles
Digital presenceArthritis National Research Foundation financial estimates
Financial estimateRevenue estimate
Valuation estimate
Arthritis National Research Foundation leadership team
Management profileNumber of profiles
Profiles3 records
Arthritis National Research Foundation subsidiaries and ownership
Company hierarchySubsidiaries1 record
Arthritis National Research Foundation funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Arthritis National Research Foundation M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Arthritis National Research Foundation
What does Arthritis National Research Foundation do?
ANRF provides research grant funding to early-career scientists conducting research on arthritis and autoimmune diseases, with the goal of advancing treatments and finding cures. The foundation also operates Immune Boost Capital, an evergreen venture fund that invests in early-stage autoimmune disease therapeutics and diagnostics, reinvesting 100% of returns to sustain ongoing research funding.
Is Arthritis National Research Foundation a public or private company?
Arthritis National Research Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Arthritis National Research Foundation founded?
Arthritis National Research Foundation was founded in 1952. It employs 1 to 10 people.
Where is Arthritis National Research Foundation based?
Arthritis National Research Foundation is headquartered in Irvine, United States, in the North America region.
How does Arthritis National Research Foundation make money?
One revenue line is on record: donations and Charitable Contributions.
Who are Arthritis National Research Foundation's main competitors?
Direct peers on record are Arthritis Foundation, National Psoriasis Foundation, Lupus Research Alliance, Sjögren's Foundation, Scleroderma Foundation and Rheumatology Research Foundation. Others are Cystic Fibrosis Foundation and Cure SMA. American College of Rheumatology is listed as a broad incumbent.
Does Arthritis National Research Foundation have an API?
No public API is recorded for Arthritis National Research Foundation.
What industry is Arthritis National Research Foundation in?
Arthritis National Research Foundation's product category is Nonprofit Medical Research Foundation. Its primary akta.pro industry code is BPAGAKAL, Health & Medical Research Grantmaking Foundations, with a secondary code of BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS). Its NAICS code is 813212 and its SIC code is 8300.